Ipilimumab (Yervoy)

Drug / Medication

The first anti-CTLA-4 drug discussed, shown to extend median survival in metastatic melanoma.

Mentioned in 1 video

Videos Mentioning Ipilimumab (Yervoy)

286‒Journal club with Andrew Huberman: light exposure on mental health & an immunotherapy for cancer

286‒Journal club with Andrew Huberman: light exposure on mental health & an immunotherapy for cancer

Peter Attia MD

The first anti-CTLA-4 drug discussed, shown to extend median survival in metastatic melanoma.